Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease (Q41719625)

8 October 2017

Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease (English)

1 reference

8 October 2017

1 reference

Shechter M

1

1 reference

8 October 2017

Merz CN

series ordinal

2

1 reference

8 October 2017

Paul-Labrador MJ

series ordinal

3

1 reference

8 October 2017

Kaul S

series ordinal

4

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

Journal of the American College of Cardiology

8 October 2017

1 reference

8 October 2017

35

1 reference

8 October 2017

300-307

1 reference

8 October 2017

2

1 reference

Diabetes and cardiovascular disease. The Framingham study

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Outcome of unstable angina in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Increased incidence of moderate stenosis among patients with diabetes: substrate for myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Platelet abnormalities in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Hemostasis variables in type I diabetic patients without demonstrable vascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Platelets from patients with diabetes mellitus have impaired ability to mediate vasodilation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Cod liver oil alters platelet-arterial wall response to injury in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Oral verapamil inhibits platelet thrombus formation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

The electronic aggregometer: a novel device for assessing platelet behavior in blood

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Low blood mononuclear cell magnesium in intensive cardiac care unit patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alpha-granules or lysosomes from, human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Insulin resistance in noninsulin-dependent diabetes mellitus. Does it exist and can it be measured?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900545-8

7 January 2021

10.1016/S0735-1097(99)00545-8

Identifiers

DOI

1 reference

8 October 2017

1 reference